ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 123 filers reported holding ARRAY BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 3.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $139,239,000 | +106.9% | 3,005,394 | +8.9% | 0.03% | +100.0% |
| Q1 2019 | $67,306,000 | -5.3% | 2,760,761 | -44.7% | 0.02% | +54.5% |
| Q4 2018 | $71,098,000 | +101.6% | 4,989,452 | +115.0% | 0.01% | +10.0% |
| Q3 2018 | $35,270,000 | -3.6% | 2,320,411 | +6.4% | 0.01% | -9.1% |
| Q2 2018 | $36,589,000 | +13.1% | 2,180,551 | +10.0% | 0.01% | 0.0% |
| Q1 2018 | $32,339,000 | +35.3% | 1,981,611 | +6.1% | 0.01% | +37.5% |
| Q4 2017 | $23,906,000 | +8.9% | 1,867,750 | +4.7% | 0.01% | 0.0% |
| Q3 2017 | $21,943,000 | +74.9% | 1,784,045 | +19.0% | 0.01% | +60.0% |
| Q2 2017 | $12,548,000 | -10.4% | 1,499,178 | -4.3% | 0.01% | -16.7% |
| Q1 2017 | $14,000,000 | +9.7% | 1,566,152 | +7.8% | 0.01% | 0.0% |
| Q4 2016 | $12,767,000 | +98.5% | 1,452,520 | +52.4% | 0.01% | +100.0% |
| Q3 2016 | $6,433,000 | +98.4% | 953,180 | +4.6% | 0.00% | +50.0% |
| Q2 2016 | $3,242,000 | +24.4% | 910,869 | +3.0% | 0.00% | +100.0% |
| Q1 2016 | $2,607,000 | -40.4% | 883,950 | -14.7% | 0.00% | -50.0% |
| Q4 2015 | $4,373,000 | +10.7% | 1,036,436 | +19.6% | 0.00% | 0.0% |
| Q3 2015 | $3,950,000 | -32.4% | 866,247 | +6.9% | 0.00% | -33.3% |
| Q2 2015 | $5,840,000 | -1.8% | 810,079 | +0.3% | 0.00% | 0.0% |
| Q1 2015 | $5,950,000 | +80.8% | 807,374 | +16.0% | 0.00% | +50.0% |
| Q4 2014 | $3,291,000 | +58.8% | 695,843 | +19.8% | 0.00% | +100.0% |
| Q3 2014 | $2,073,000 | -20.3% | 580,949 | +1.9% | 0.00% | -50.0% |
| Q2 2014 | $2,600,000 | -1.8% | 570,348 | +1.2% | 0.00% | 0.0% |
| Q1 2014 | $2,649,000 | -0.5% | 563,781 | +6.1% | 0.00% | 0.0% |
| Q4 2013 | $2,661,000 | -17.7% | 531,183 | +2.2% | 0.00% | -33.3% |
| Q3 2013 | $3,233,000 | +49.0% | 519,794 | +8.7% | 0.00% | +50.0% |
| Q2 2013 | $2,170,000 | – | 478,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |